# 2026-19699: Eli Lilly Gets FTZ Green Light for Drug Making in NC

2026-19699, Foreign-Trade Zone (FTZ) 57, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Concord, North Carolina, is a Federal Register notice from Commerce Department, Foreign-Trade Zones Board published 2026-09-25; PRIA reads it as touching household money (as of 2026-10-02).

- Canonical: https://policyrisk.com/federal-register/2026-19699
- As of: 2026-10-02
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-19699
- Title: Foreign-Trade Zone (FTZ) 57, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Concord, North Carolina
- Type: Notice
- Agencies: Commerce Department; Foreign-Trade Zones Board
- Citation: 91 FR 60933
- Published: 2026-09-25
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-10-02

## In one line

Eli Lilly Gets FTZ Green Light for Drug Making in NC

## Summary

Eli Lilly wants to start making several important drug products at their Concord, North Carolina facility under special Foreign-Trade Zone rules. This move helps them save on import duties for certain materials while producing medicines for diabetes, migraines, inflammation, weight management, and Alzheimer's. The government got their request on September 17, 2026, and is reviewing it to give the green light soon.

## Effects PRIA read

- Eli Lilly seeks duty-free FTZ production: benefit, high. Eli Lilly notified the Foreign-Trade Zones Board on September 17, 2026 that it wants to produce multiple drug products at its Concord, North Carolina facility within FTZ Subzone 57F. The listed finished products (including incretin-based therapies, CGRP monoclonal antibody products for migraine pre…
- Some inputs may still face 232/301 duties: cost, medium. The request states certain materials/components may be subject to duties under section 232 of the Trade Expansion Act of 1962 or section 301 of the Trade Act of 1974 depending on country of origin. Those subject merchandise items must be admitted to FTZs in "privileged foreign status" as described…

## Related documents

- [2026-20775](https://policyrisk.com/federal-register/2026-20775): Foreign-Trade Zone (FTZ) 40, Notification of Proposed Production Activity; Norman Noble Company Inc.; (Implantable Medical Devices); Highla…, 2026-10-09
- [2026-20774](https://policyrisk.com/federal-register/2026-20774): Foreign-Trade Zone (FTZ) 16, Notification of Proposed Production Activity; Yazaki North America, Inc.; (Stamped Copper Terminals); Petoskey…, 2026-10-09
- [2026-20776](https://policyrisk.com/federal-register/2026-20776): Foreign-Trade Zone (FTZ) 50, Notification of Proposed Production Activity; Sanyo Denki America, Inc.; (Cooling, Servo, and Power Systems an…, 2026-10-09
- [2026-20253](https://policyrisk.com/federal-register/2026-20253): Foreign-Trade Zone (FTZ) 75; Authorization of Production Activity; Essai, Inc.; (Semiconductor Test Equipment); Chandler, Arizona, 2026-10-02
- [2026-20261](https://policyrisk.com/federal-register/2026-20261): Foreign-Trade Zone (FTZ) 153; Authorization of Limited Production Activity; CMS Circuits, Inc.; (Electronic Manufacturing Services in Aeros…, 2026-10-02
- [2026-20254](https://policyrisk.com/federal-register/2026-20254): Foreign-Trade Zone (FTZ) 45; Authorization of Limited Production Activity; Qorvo US, Inc.; (Semiconductor Wafers and Modules); Hillsboro, O…, 2026-10-02

## Sources
- [2026-19699 on federalregister.gov](https://www.federalregister.gov/documents/2026/09/25/2026-19699/foreign-trade-zone-ftz-57-notification-of-proposed-production-activity-eli-lilly-and-company-drug)
- [2026-19699 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-09-25/pdf/2026-19699.pdf)

## Related
- [Previous: 2026-19698, Foreign-Trade Zone (FTZ) 93, Notification of Proposed Production Activity; Eli…](https://policyrisk.com/federal-register/2026-19698)
- [Next: 2026-19700, Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establ…](https://policyrisk.com/federal-register/2026-19700)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-19699 (as of 2026-10-02).